These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12464717

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bioavailability of L-dopa after Madopar HBS administration in healthy volunteers.
    Crevoisier C, Hoevels B, Zürcher G, Da Prada M.
    Eur Neurol; 1987; 27 Suppl 1():36-46. PubMed ID: 3428308
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of COMT inhibition by tolcapone on tolerability and pharmacokinetics of different levodopa/benserazide formulations.
    Jorga K, Fotteler B, Schmitt M, Nielsen T, Zürcher G, Aitken J.
    Eur Neurol; 1997; 38(1):59-67. PubMed ID: 9252801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
    Marion MH, Stocchi F, Malcolm SL, Quinn NP, Jenner P, Marsden CD.
    Eur Neurol; 1987; 27 Suppl 1():54-8. PubMed ID: 3322837
    [Abstract] [Full Text] [Related]

  • 11. Single-dose pharmacokinetics of Madopar HBS in patients and effect of food and antacid on the absorption of Madopar HBS in volunteers.
    Malcolm SL, Allen JG, Bird H, Quinn NP, Marion MH, Marsden CD, O'Leary CG.
    Eur Neurol; 1987; 27 Suppl 1():28-35. PubMed ID: 3428307
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE, Schrag A, Trenkwalder C, Selzer R, Kohnen R, Oertel WH, Poewe W.
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 18. Preliminary experience with Madopar HBS: clinical observations and plasma levodopa concentrations.
    Fischer PA, Baas H.
    Eur Neurol; 1987 Nov; 27 Suppl 1():81-7. PubMed ID: 3322840
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg : randomized, double-blind, placebo-controlled, crossover study in healthy subjects.
    Vaz-da-Silva M, Loureiro AI, Nunes T, Lopes C, Rocha J, Machado R, Costa R, Torrão L, Falcão A, Wright L, Almeida L, Soares-da-Silva P.
    Drugs R D; 2008 Nov; 9(6):435-46. PubMed ID: 18989992
    [Abstract] [Full Text] [Related]

  • 20. The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers.
    Wen AD, Jia YY, Luo XX, Bi LL, Chen XY, Zhong DF.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):774-8. PubMed ID: 17055209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.